Back

4D Molecular Therapeutics Stock Predictions

My #1 Coin is...

All the details are on the next page.

Sell

FDMT
4D Molecular Therapeutics

Last Price:

23.21

Seasonality Move:

-11.17%

7 Day Trial

ALL ACCESS PASS

$ 7

20 Most Hated Stocks on Wall Street

Click here to see the full list and protect yourself before it's too late.

4D Molecular Therapeutics Stock Forecast

Over the next 52 weeks, 4D Molecular Therapeutics has on average historically risen by 8.1% based on the past 3 years of stock performance.
4D Molecular Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Is 4D Molecular Therapeutics Stock Undervalued?
The current 4D Molecular Therapeutics [FDMT] share price is $23.25. The Score for FDMT is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
FDMT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will 4D Molecular Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, 4D Molecular Therapeutics has on average historically risen by 8.1% based on the past 3 years of stock performance.

4D Molecular Therapeutics Stock Rating

Sell

4D Molecular Therapeutics (FDMT) is a Sell

Is 4D Molecular Therapeutics overpriced?

4D Molecular Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

4D Molecular Therapeutics Stock Price History

Is FDMT stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

4dmoleculartherapeutics.com

52-Week Data

52-Week High:

36.25

52-Week Low:

9.44

Prediction Charts

Market Cap:

1.16B

Price in USD:

23.25

Volume:

322.45K

Beta:

2.93

Technical Analysis

SMA50:

28.52

SMA100:

24.18

SMA200:

19.19

52-Wk Change:

13.03%

Stock Predictions

Is 4D Molecular Therapeutics stock public?
Yes, 4D Molecular Therapeutics is a publicly traded company.
What is the 4D Molecular Therapeutics stock quote today?
The 4D Molecular Therapeutics stock price is 23.25 USD today.
How to buy 4D Molecular Therapeutics stock online?
You can buy 4D Molecular Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-9	28.79	27.11	29.22	26.80
Apr-10	26.50	26.89	27.29	25.68
Apr-11	27.19	27.74	27.87	26.60
Apr-12	27.53	26.40	27.72	26.09
Apr-15	27.89	26.21	28.43	25.94
Apr-16	25.74	26.75	27.24	25.74
Apr-17	26.94	25.30	26.99	25.15
Apr-18	25.04	24.76	25.27	24.71
Apr-19	24.61	25.28	25.56	24.38
Apr-22	25.60	26.43	26.92	24.57
Apr-23	26.45	24.81	26.89	24.69
Apr-24	25.19	24.25	25.38	24.23
Apr-25	23.51	23.53	23.98	22.91
Apr-26	23.45	23.25	23.86	22.75

4D Molecular Therapeutics Earnings

4D Molecular Therapeutics Earnings Report: Per Share 4D Molecular Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

4D Molecular Therapeutics Forecast Revenue Growth

4D Molecular Therapeutics Stock Analysis: Historical quarterly revenues per share for 4D Molecular Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.32 per share.

* 4D Molecular Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.